HIV/AIDS, Hepatitis, Infectious Disease News | STD Treatment …
The Infectious Diseases Society of America aimed to develop up-to-date guidance focusing on the treatment of antimicrobial-resistant gram-negative infections. Following the approval of Casgevy for the treatment of sickle cell disease, a crusade of clinical trials are centering the therapeutic potential of CRISPR technologies.
Streptococcus - Infectious Disease Advisor
Jan 25, 2024 · Streptococci are gram-positive bacteria that make up normal microbial flora of humans and animals. 1 In humans, they commonly inhabit the upper respiratory tract, urogenital tract, gastrointestinal tract, and oral cavity. 2 Streptococci are classified into α, β, and γ based on their hemolytic properties in blood agar medium. 1 These bacteria ...
Review of 2023 IDSA Guidelines on AMR Gram-Negative Infections
August 18, 2023. The Infectious Diseases Society of America (IDSA) has released updated guidelines on the treatment of antimicrobial-resistant (AMR) gram-negative infections. The updated guidance was published in Clinical Infectious Diseases. The updated guidelines cover preferred and alternative treatment options for 6 AMR gram-negative ...
Coagulase-Negative Staphylococcus - Infectious Disease Advisor
Feb 16, 2024 · Coagulase-negative staphylococci (CoNS) species are skin commensal bacteria typically encountered in hospital settings. 1 In the United States, they are the most common cause of health care-related infections. 2 There are more than 30 species of CoNS, and approximately 50% are known to colonize in humans. 2 Coagulase-negative staphylococci typically causes infection when there is a foreign ...
RSV Symptoms, Diagnosis, Treatment, & Prevention
Aug 9, 2024 · In hospital settings, adults most commonly experience cough, congestion, fever, weakness, and irregular breathing. In immunocompromised adult patients, the most common symptoms include cough, fever, and irregular breathing. Symptoms of RSV in adult patients can last up to 20 days, and hospital LOS can range from approximately 3 to 20 days ...
Type O and Rh-Negative Blood Type Protective Against COVID-19
The relative protective effects of O, Rh-, and O- blood groups were greatest in patients younger than age 70. Secondary outcome results indicated that type O blood group had an aRR of 0.87 (95% CI, 0.78-0.97) for severe COVID-19 illness and death versus all other blood groups and Rh- status had an aRR of 0.82 (95% CI, 0.68–0.96) compared to ...
Complicated Intra-Abdominal Infections IDSA Update - Infectious …
Aug 23, 2024 · The Infectious Diseases Society of America (IDSA) has released updated guidelines on the risk assessment, diagnostic imaging, and microbiologic evaluation of complicated intra-abdominal infections (IAIs). The new guidance was published in Clinical Infectious Diseases and is the first part of an expected 8-part series.
Streptococcus Pneumoniae - Infectious Disease Advisor
Sep 22, 2023 · Streptococcus pneumoniae, also known as pneumococcus, is a bacterium that commonly causes disease in humans.First identified in 1881 by Louis Pasteur, S pneumoniae is a gram-positive, lancet-shaped, facultative anaerobe that is usually observed in pairs and is usually encapsulated. 1 Figure. Streptococcus pneumoniae bacteria.Credit: Getty Images.. The first vaccine against pneumococcal disease ...
News and Features - Infectious Disease Advisor
IDSA 2024 Guidance on Antimicrobial-Resistant Gram-Negative Infections. By Paul Basilio. The Infectious Diseases Society of America aimed to develop up-to-date guidance focusing on the treatment of antimicrobial-resistant gram-negative infections.
Guideline Update: Revised Consensus for Vancomycin Dosing and ...
Jul 29, 2020 · A newly revised consensus guideline has provided updated recommendations for clinicians treating serious methicillin-resistant Staphylococcus aureus (MRSA) to better achieve clinical efficacy and ensure patient safety.An executive summary of the revised guideline was published in Clinical Infectious Diseases.. Based on recent clinical data, a reevaluation of vancomycin dosing and monitoring ...